Shorted
Ebos Group logo
EBO
Health Care Equipment & Services

Ebos Group

Short interest
0.46%
−0.13 pp 30d
as of 13 Oct 2026
Reported shorts
957K
Shares on issue
209.054M

Ebos Group (EBO) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
1d ago

Is Private Equity Eyeing a Bargain in Ebos Group (ASX:EBO)?

Highlights Ebos Group has reportedly attracted private equity takeover interest after a period of share price weakness. Investment bankers are said to be sounding out potential buyers. No proposal has been announced. Ebos Group (ASX:EBO), the trans-Tasman healthcare and animal care distributor, is reportedly drawing interest from private equity. The report comes after a stretch of share price weakness, putting Ebos in focus among ASX Value Stocks. What is being reported? According to a weekly...

Continue reading
Kalkine
Neutral
9 Oct

Has Ebos Group (ASX:EBO) Finished Its Heavy Spending Cycle?

Highlights The healthcare distributor says its major logistics rebuild is complete Animal care and pharmacy brands are expected to drive the next leg of growth Fuel costs, currency swings and a lost New Zealand contract nibble at earnings Ebos Group (ASX:EBO), the Australasian distributor of medicines, medical devices and pet products, says its long distribution centre rebuild is finished, and the market is now asking how quickly lower capital spending turns into stronger cash and returns. It...

Continue reading
Kalkine
Neutral
8 Oct

EBOS Group Announces Expiry of 3,419 Performance Rights Effective 7 October 2026

EBOS Group Limited (ASX:EBO) has announced that 3,419 performance rights under the security code EBOAA expired on 7 October 2026, after it was determined that the conditions tied to these rights were either unmet or no longer achievable. Key Points 3,419 EBOAA performance rights expired on 7 October 2026 due to unmet or unattainable conditions No payment was made by EBOS Group for the termination of these securities Post-expiry, 989,266 unquoted EBOAA performance rights remain outstanding Tot...

Continue reading
Kalkine
Neutral
1 Oct

Which forces are steering EBOS Group (ASX:EBO) this month?

Highlights EBOS Group has issued new shares under its dividend plan, adding modestly to its register after the final payout. The healthcare and animal care distributor delivered a largely no-surprises full-year result in August. Higher interest rates and the sector's defensive rotation frame the outlook for the trans-Tasman group. EBOS Group (ASX:EBO) enters October with fresh shares on issue after applying for quotation of new ordinary shares under its dividend plan, completing the capital m...

Continue reading
Kalkine
Neutral
28 Sept

Will EBOS (ASX:EBO) Chart Stay Defensive Into The RBA Call?

Highlights The healthcare and animal care distributor issued new shares under its dividend plan this month after a full-year result that lifted earnings guidance. Healthcare was among the steadier sectors during last week's market slide, and the stock's chart reflects that defensive character with a relatively contained range. The price is moving between a demand zone formed after the August result and overhead supply from earlier in the year, with moving averages converging. EBOS Group (ASX:...

Continue reading
Kalkine
Neutral
27 Aug

Why Could EBOS Group (ASX:EBO) Reshape the Healthcare Stocks Outlook?

Highlights For Australian equities, EBOS Group (ASX:EBO) brings a company-specific lens to a market still sorting through reporting-season signals. The the broader market context matters, but the more useful reading will come from how the business addresses patient volumes, product adoption, regulatory pathways and operating leverage. The next useful checkpoint for EBOS Group is whether its latest disclosure adds clearer evidence on execution, operating discipline and financial flexibility with...

Continue reading
Kalkine
Neutral
20 Aug

Why Is EBOS Group (ASX:EBO) in Focus on Market Update?

Highlights EBOS Group shares rose after full-year revenue and earnings both climbed at a double-digit pace across its healthcare distribution network The community pharmacy and animal care segments both contributed to broad-based growth across the diversified healthcare business Management flagged continued expansion of its distribution footprint as the primary driver of the medium-term growth outlook Trans-Tasman healthcare distribution group EBOS Group (ASX:EBO) rose after releasing full-ye...

Continue reading
Kalkine
Neutral
31 July

How Is EBOS (ASX:EBO) Framing the ASX Test?

Highlights EBOS is being read through distribution defensiveness as defensive medical earnings returns to local screens Fresh ASX sentiment is linking healthcare returning to screens after softer inflation eased pressure on long-duration names with company-level execution rather than broad excitement Readers are focusing on wholesale margins and pharmacy demand without turning the sector story into instruction The latest ASX conversation is less about a single headline and more about whether c...

Continue reading